A nasal spray that's having life-changing impacts on people living with depression is set to be listed on the Pharmaceutical Benefits Scheme (PBS), slashing the cost and improving accessibility. It's ...
A new ketamine-like nasal spray will soon be available at a subsidised cost in Australia to help thousands living with treatment-resistant depression. The medication, called Spravato (esketamine), has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback